Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: A prospective, randomized, multicenter trial.

被引：0
|
作者：
Minematsu, K [1 ]
Yasaka, M [1 ]
Yamaguchi, T [1 ]
机构：
[1] Natl Cardiovasc Ctr, Osaka, Japan
来源：
STROKE | 1999年 / 30卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
60
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [41] Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study
    Larsen, Torben Bjerregaard
    Rasmussen, Lars Hvilsted
    Gorst-Rasmussen, Anders
    Skjoth, Flemming
    Lane, Deirdre A.
    Lip, Gregory Y. H.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2014, 127 (12): : 1172 - +
  • [42] Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation
    Lewis, William R.
    Fonarow, Gregg C.
    LaBresh, Kenneth A.
    Cannon, Christopher P.
    Pan, Wenqin
    Super, Dennis M.
    Sororf, Suzanne A.
    Schwamm, Lee H.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (02): : 227 - 231
  • [43] Cost-Utility Analysis of Dabigatran and Warfarin for Stroke Prevention Among Patients With Nonvalvular Atrial Fibrillation in India
    Aghoram, Rajeswari
    Kumar, S. Mathan
    Rajasulochana, Subramania Raju
    Kar, Sitanshu Sekhar
    Aggarwal, Rakesh
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2022, 31 : 119 - 126
  • [44] Transient ischemic attacks in patients with atrial fibrillation - Implications for secondary prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial
    Hart, RG
    Pearce, LA
    Koudstaal, PJ
    [J]. STROKE, 2004, 35 (04) : 948 - 951
  • [45] Cost-effectiveness Analysis of Apixaban against Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation in Japan
    Kamae, Isao
    Hashimoto, Yoichiro
    Koretsune, Yukihiro
    Tanahashi, Norio
    Murata, Tatsunori
    Phatak, Hemant
    Liu, Larry Z.
    Tang, Ann C.
    Wang, Peter Feng
    Okumura, Ken
    [J]. CLINICAL THERAPEUTICS, 2015, 37 (12) : 2837 - 2851
  • [46] Use of rivaroxaban for the prevention of stroke in patients with nonvalvular atrial fibrillation in Spain
    Marti, Edelmira
    Segado, Alejandra
    Pastor-Galan, Irene
    Amat, Paula
    Jose Remigia, Maria
    Solano, Carlos
    Navarro, Blanca
    [J]. FUTURE CARDIOLOGY, 2018, 14 (03) : 3 - 8
  • [47] APIXABAN COMPARED WITH WARFARIN IN PATIENTS WITH DIABETES AND NONVALVULAR ATRIAL FIBRILLATION IN THE ARISTOTLE TRIAL
    Ezekowitz, Justin A.
    Lewis, Basil
    Lopes, Renato
    Wojdyla, Daniel
    McMurray, John
    Hanna, Michael
    Atar, Dan
    Bahit, Maria
    Keltai, Matyas
    Lopez-Sendon, Jose
    Pais, Prem
    Ruzyllo, Witold
    Wallentin, Lars
    Alexander, John
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A372 - A372
  • [48] Dual antiplatelet therapy is not optimal for stroke prevention in patients with atrial fibrillation
    Chamorro, A.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2010, 5 (01) : 28 - 29
  • [49] Primary stroke prevention in nonvalvular atrial fibrillation: Implementing the clinical trial findings
    Howard, PA
    Duncan, PW
    [J]. ANNALS OF PHARMACOTHERAPY, 1997, 31 (10) : 1187 - 1196
  • [50] Stroke Prevention in Very Elderly Patients With Nonvalvular Atrial Fibrillation Revisited
    Alkhouli, Mohamad
    [J]. MAYO CLINIC PROCEEDINGS, 2021, 96 (01) : 13 - 15
12345